Automated Medication Transfer Between a Pharmacy Dispensing System and a Mobile D
Automated Medication Transfer Between a Pharmacy Dispensing System and a Mobile D
批准号:
8001596
负责人:
DANIEL A THEOBALD
金额:
$7.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-10 至 2011-01-31
关键词:
AccountabilityAccountingAddressAutomationBostonCessation of lifeClientClinicalClinical Decision Support SystemsComputer softwareComputerized Medical RecordCoupledDataDevelopmentDiscipline of NursingDockingDoseEconomic BurdenElectronicsEnsureEventFeasibility StudiesGoalsHealthHealthcareHospitalsHourHousingHumanHuman ResourcesIndustryInjuryInstitute of Medicine (U.S.)LabelLeadLeftLength of StayLinkManualsMarketingMedical centerMedication ErrorsMethodologyMovementNursesPatient RightsPatientsPharmaceutical PreparationsPharmacy facilityPhaseProceduresProcessProtocols documentationProviderReportingResearchRestRiskRobotRoboticsScanningSecureSideSiteSmall Business Innovation Research GrantSoftware DesignSolutionsSourceStagingSystemSystems IntegrationTechnologyTestingTimeUnited States National Institutes of HealthWomanWorkbasecomputerizedcostdesignevaluation/testingexperienceimprovedinnovationinterestmortalitypatient safetyphase 1 studyprototypepublic health relevancesuccess
中文摘要
描述(由申请人提供):Vecna Technologies,Inc.(Vecna)是医院自动化、系统集成和机器人领域的市场领导者,它看到了一个巨大的机会,可以通过QC BotTM将自动化药房配药系统的优势扩展到医院的其他部分,QC BotTM是一种自动化移动的药物安全存储和交付单元,具有与医院电子病历(EMR)的开放标准集成。QC Bot将关闭从CPOE输入到药物管理的处方履行自动化循环,直接与药房分配系统连接,并安全可靠地将药物交付给单位护理站或管理点,将自动化药房的优势与当前成功的智能柜和条形码扫描系统的优势相结合。 虽然目前的电子药物跟踪和会计系统在患者安全方面已经显示出可量化的改善,但在处方履行链中仍然存在重要的缺失。从药物离开药房到给患者用药,仍然存在手动过程。这些手动步骤打破了自动化的监管责任链,这可能会在药物输送和管理过程中引入危险的错误和效率低下。 QC机器人将填补这一链条中缺失的环节,确保正确的药物,正确的剂量,在正确的时间到达正确的患者。其结果将是改善患者健康,降低成本,伤害和死亡率。 完全开发的自动化药物输送解决方案必须解决药房站和输送系统之间的有效药物转移、输送系统从药房到单元护理的安全和可靠的移动、以及单元护理站处的安全药物分配和有效的护士工作流程。对于这项拟议的第一阶段研究,Vecna将专注于第一阶段,即在药房站和自动输送系统之间有效地转移药物。 有效地将药物转移到输送系统将需要适当的物理接口以及EMR集成的软件接口。Vecna将与其合作伙伴和支持者合作,包括Innovation Associates,Brigham and Women's Hospital和Boston Medical Center,以设计和测试将药物以安全,可靠和负责任的方式转移到QC Bot系统所需的软件和硬件解决方案的可行性。 Vecna假设,如果可行性研究和由此提出的方案、程序和机制成功,将导致简化的第二阶段设计和原型阶段。Vecna在之前的SBIR项目中的I - III阶段取得了很好的成功,并欢迎有机会与NIH合作进一步发展这一概念。2009 Vecna Technologies,Inc.
公共卫生相关性:该项目的长期目标是开发一种自动化的输送系统,作为药房配药系统和药物管理点之间的中介。它将关闭两点之间的自动化回路,从而显著减少或消除由于外部来源(如人为错误)而导致的可预防错误。该系统的有效实施将为供应链的问责制提供透明度,并通过降低成本、伤害和死亡率来改善患者健康。
英文摘要
DESCRIPTION (provided by applicant): Vecna Technologies, Inc. (Vecna), a market leader in hospital automation, systems integration, and robotics, sees a tremendous opportunity to extend the benefits of automated pharmacy dispensing systems throughout the rest of the hospital with the QC BotTM, an automated mobile medications secure storage and delivery unit with open standard integration to the hospital Electronic Medical Record (EMR). QC Bot will close the automation loop on prescription fulfillment from CPOE entry to medication administration by interfacing directly with the pharmacy dispensing system and safely and securely delivering the medications to the unit nursing station or point of administration, merging the benefits of the automated pharmacy with those of the current successful smart cabinet and barcode scanning systems. While the current electronic medication tracking and accounting systems have shown quantifiable improvements in patient safety, there is still an important missing piece in the prescription fulfillment chain. Manual processes still exist from the point that the medication leaves the pharmacy until it is administered to the patient. These manual steps break the automated accountability chain of custody which can introduce dangerous errors and inefficiencies into the medication delivery and administration process. The QC Bot will fill the missing link in this chain, ensuring that the right drug, in the right dose, gets to the right patient at the right time. The result will be improved patient health, and reductions in cost, injury, and mortality. A fully developed automated medication delivery solution must address the efficient medication transfer between the pharmacy station and delivery system, the safe and secure movement of the delivery system from the pharmacy to the unit nursing, and safe medication distribution and efficient nurse work- flow at the unit nursing station. For this proposed Phase I study, Vecna will focus on the first stage, the efficient transfer of medication between the pharmacy station and the automated delivery system. Efficient medication transfer to the delivery system will require both a proper physical interface as well as an EMR integrated software interface. Vecna will work with its collaborators and supporters, including Innovation Associates, Brigham and Women's Hospital and Boston Medical Center, to design test the feasibility of the required software and hardware solutions necessary for the transfer of medication to a QC Bot system in a safe, secure, and accountable manner. Vecna hypothesizes that the feasibility studies and resultant proposed protocols, procedures, and mechanisms, if successful, will lead to a streamlined Phase II design and prototyping stage. Vecna has a strong record of success in Phases I - III in previous SBIR projects and welcomes the opportunity to work with NIH on developing this concept further. 3 of 18 Proprietary c 2009 Vecna Technologies, Inc.
PUBLIC HEALTH RELEVANCE: The long term goal of this project is to develop an automated delivery system that will operate as intermediary between a pharmacy dispensing system and the point of administration for medication. It will close the automation loop between the two points, thereby significantly reducing or eliminating preventable errors due to external sources, such as human error. Effective implementation of the system will provide transparency for accountability in the supply chain and improve patient health by reducing costs, injuries, and mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signal-Based Analysis of Clinical Microbiology
-
批准号:6443486
-
项目类别:
-
资助金额:$66.94万
-
财政年份:2000
-
负责人:DANIEL A THEOBALD
-
依托单位:
SIGNAL-BASED ANALYSIS OF CLINICAL MICROBIOLOGY
-
批准号:6211877
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2000
-
负责人:DANIEL A THEOBALD
-
依托单位:
海外基金